Comparative Study between the Effect of Dexmedetomidine versus Dexamethasone as Adjuvant to Levobupivacaine in Interscalene Block using Ultrasound in Shoulder Arthroscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202501899436228

Enrollment

120

Registered

2025-01-16

Start date

2024-05-16

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Dexmedetomidine versus Dexamethasone as Adjuvant to Levobupivacaine in Interscalene Block.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients of American Society of Anesthesiologists (ASA) physical status I or II both sexes aged 20-60 years scheduled for elective shoulder arthroscopic surgery under ultrasound-guided interscalene brachial plexus block

Exclusion criteria

Exclusion criteria: Patients who had allergy to any drug used in the study, chronic illness (HTN, Cardiac, Hepatic,…), under treatment of any a2 agonist or antagonist agents, pregnant women, psychiatric patients drug abusers, history or clinical evidence of central or peripheral neurological disease, coagulopathy or anticoagulant/antiaggregant therapy, infection at the site of the block, contralateral phrenic nerve paresis, and anatomical or vascular abnormality in the upper extremity

Design outcomes

Primary

Measure	Time frame
measuring cortisol levels and assessing stress response	—

Secondary

Measure	Time frame
complications such as hematoma, and vascular injury to zero %. Also, there was no incidence of seizures or neuro-axial block	—

Countries

Egypt

Contacts

Public ContactMohamed Abo Elenain

lecturer

aboelenainmohamed@gmail.com+201008121985

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026